These were cell lines used previously in our initial evaluation of the anticancer activity of Br-Cla [6]; so, their use here will allow us to further assess the relative potency of Br-Cla and Clm-1 in cell lines other than those of lung and gastric cancer [9]. Here, CD300LF is linked to gastric cancer.